Skip to main content

Table 3 Ultrasonographic changes during the course of treatment

From: Sofosbuvir and daclatasvir are safe and effective in treatment of recurrent hepatitis C virus in Egyptian patients underwent living donor liver transplantation

Item

Frequency

Percentage

US before treatment

 Splenomegaly

6

155

 Normal

24

85

US 1 month after starting treatment

 HFL

0

0

 No HFL

40

100

US after the end of treatment

 HFL

0

0

 No HFL

40

100

US 3 months after the end of treatment

 HFL

0

0

 No HFL

40

100

US 6 months after the end of treatment

 HFL

0

0

 No HFL

40

100

US 9 months after the end of treatment

 HFL

0

0

 No HFL

40

100

  1. HFL hepatic focal lesion